Key result
Cardiovascular toxicity associated with anti-cancer treatment requires regular monitoring with cardiac imaging and biomarkers for early detection and management.
Population
Patients receiving anti-cancer treatment at risk for cardiovascular toxicity
Design
Review
Authors
Loading...
Emphasizes anthracycline cardiotoxicity burden in oncology; leaves open optimal risk stratification and monitoring protocols.
This review outlines the mechanisms and clinical management of cardiovascular toxicities related to anti-cancer therapies, highlighting the importance of early detection through cardiac imaging.
Kim et al. (2018) conducted a review in Cardiovascular toxicity related to anti-cancer treatment. Anti-cancer treatment was evaluated. Cardiovascular toxicity associated with anti-cancer treatment requires regular monitoring with cardiac imaging and biomarkers for early detection and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: